These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7248140)

  • 21. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis.
    Fillastre JP; Taburet AM; Fialaire A; Etienne I; Bidault R; Singlas E
    Drugs Exp Clin Res; 1993; 19(1):25-32. PubMed ID: 8223137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of ciprofloxacin in patients with impaired renal function.
    Boelaert J; Valcke Y; Schurgers M; Daneels R; Rosseneu M; Rosseel MT; Bogaert MG
    J Antimicrob Chemother; 1985 Jul; 16(1):87-93. PubMed ID: 2931415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketanserin pharmacokinetics in patients with renal failure.
    Barendregt JN; Van Peer A; Van Der Hoeven JG; Van Oene JC; Tjandra YI
    Br J Clin Pharmacol; 1990 Jun; 29(6):715-23. PubMed ID: 2378791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricyclic antidepressant and metabolite levels in chronic renal failure.
    Lieberman JA; Cooper TB; Suckow RF; Steinberg H; Borenstein M; Brenner R; Kane JM
    Clin Pharmacol Ther; 1985 Mar; 37(3):301-7. PubMed ID: 3971655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacokinetic study of roxatidine acetate in chronic renal failure.
    Lameire N; Rosenkranz B; Maass L; Brockmeier D
    Drugs; 1988; 35 Suppl 3():48-52. PubMed ID: 2905249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran.
    Eriksson UG; Johansson S; Attman PO; Mulec H; Frison L; Fager G; Samuelsson O
    Clin Pharmacokinet; 2003; 42(8):743-53. PubMed ID: 12846595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of brotizolam in renal failure.
    Evers J; Renner E; Bechtel WD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):309S-313S. PubMed ID: 6661376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of perphenazine with the kinetics of nortriptyline.
    Overo KF; Gram LF; Hansen V
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):97-105. PubMed ID: 576367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenous and oral amitriptyline and its active metabolite nortriptyline in Greyhound dogs.
    Norkus C; Rankin D; KuKanich B
    Vet Anaesth Analg; 2015 Nov; 42(6):580-9. PubMed ID: 25683584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of nifurtimox in chronic renal failure.
    González-Martin G; Thambo S; Paulos C; Vásquez I; Paredes J
    Eur J Clin Pharmacol; 1992; 42(6):671-3. PubMed ID: 1623911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of digoxin in Nigerians.
    Iyun AO; Lukanbi FA
    Afr J Med Med Sci; 1988 Mar; 17(1):9-15. PubMed ID: 2834936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination kinetics of labetalol in severe renal failure.
    Wood AJ; Ferry DG; Bailey RR
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):81S-86S. PubMed ID: 7093103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
    Kelly JG; Doyle GD; Carmody M; Glover DR; Cooper WD
    Br J Clin Pharmacol; 1988 Dec; 26(6):781-6. PubMed ID: 2853960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.